In a report released today, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx (OPRX – Research Report), with a ...
Federal health scientists voice concern over an anticipated takeover by medical skeptics in Trump’s second administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback